$BHC
Bausch Health Companies Inc.

2017 Q4 Form 10-Q Financial Statement

#000088559017000070 Filed on November 07, 2017

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2016 Q3
Revenue $2.163B $2.219B $2.479B
YoY Change -9.99% -10.49% -11.05%
Cost Of Revenue $647.0M $650.0M $649.0M
YoY Change -2.75% 0.15% 2.27%
Gross Profit $1.516B $1.569B $1.830B
YoY Change -12.74% -14.26% -14.98%
Gross Profit Margin 70.09% 70.71% 73.82%
Selling, General & Admin $639.0M $623.0M $661.0M
YoY Change -3.91% -5.75% -5.25%
% of Gross Profit 42.15% 39.71% 36.12%
Research & Development $90.00M $81.00M $101.0M
YoY Change -3.02% -19.8% -0.59%
% of Gross Profit 5.94% 5.16% 5.52%
Depreciation & Amortization $819.0M $698.0M $708.0M
YoY Change 15.84% -1.41% -2.53%
% of Gross Profit 54.02% 44.49% 38.69%
Operating Expenses $1.506B $704.0M $762.0M
YoY Change 32.57% -7.61% -4.65%
Operating Profit -$322.0M $38.00M -$863.0M
YoY Change -314.67% -104.4% -292.63%
Interest Expense -$425.0M -$437.0M -$469.4M
YoY Change -16.73% -6.9% 3.51%
% of Operating Profit -1150.0%
Other Income/Expense, Net $325.0M -$1.000M
YoY Change -32600.0%
Pretax Income -$804.0M -$400.0M -$1.332B
YoY Change 123.27% -69.97% 23268.42%
Income Tax -$341.0M -$1.700B -$113.0M
% Of Pretax Income
Net Earnings $513.0M $1.300B -$1.219B
YoY Change -199.69% -206.64% -2457.83%
Net Earnings / Revenue 23.72% 58.58% -49.17%
Basic Earnings Per Share $1.46 $3.71 -$3.49
Diluted Earnings Per Share $1.45 $3.69 -$3.49
COMMON SHARES
Basic Shares Outstanding 348.6M shares 350.4M shares 349.5M shares
Diluted Shares Outstanding 352.3M shares 349.5M shares

Balance Sheet

Concept 2017 Q4 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $720.0M $964.0M $659.0M
YoY Change 32.84% 46.28% -53.59%
Cash & Equivalents $720.0M $964.0M $659.0M
Short-Term Investments
Other Short-Term Assets $848.0M $1.680B $1.007B
YoY Change -11.39% 66.83% -40.06%
Inventory $1.048B $1.071B $1.300B
Prepaid Expenses
Receivables $2.130B $2.229B $2.708B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.746B $5.944B $5.674B
YoY Change -6.52% 4.76% -18.9%
LONG-TERM ASSETS
Property, Plant & Equipment $1.403B $1.398B $1.462B
YoY Change 6.94% -4.38% 8.18%
Goodwill $15.59B $15.57B $17.45B
YoY Change -1.27% -10.76% 0.43%
Intangibles $15.21B $16.02B $20.51B
YoY Change -19.45% -21.87% -8.37%
Long-Term Investments
YoY Change
Other Assets $111.0M $152.0M $213.6M
YoY Change -39.67% -28.84% -9.53%
Total Long-Term Assets $32.75B $34.03B $40.09B
YoY Change -14.83% -15.11% -3.31%
TOTAL ASSETS
Total Short-Term Assets $4.746B $5.944B $5.674B
Total Long-Term Assets $32.75B $34.03B $40.09B
Total Assets $37.50B $39.97B $45.76B
YoY Change -13.86% -12.65% -5.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $365.0M $407.0M $358.7M
YoY Change 12.65% 13.47% -24.77%
Accrued Expenses $3.694B $3.396B $3.392B
YoY Change 14.47% 0.12% 2.98%
Deferred Revenue
YoY Change
Short-Term Debt $905.0M $684.0M $0.00
YoY Change 14983.33%
Long-Term Debt Due $209.0M $925.0M $59.00M
YoY Change 20800.0% 1467.8% -91.65%
Total Short-Term Liabilities $4.268B $4.728B $3.897B
YoY Change 18.26% 21.33% -16.21%
LONG-TERM LIABILITIES
Long-Term Debt $25.24B $26.22B $30.39B
YoY Change -15.45% -13.72% 0.7%
Other Long-Term Liabilities $526.0M $102.0M $165.0M
YoY Change 8.23% -38.18% -21.09%
Total Long-Term Liabilities $25.76B $26.32B $30.55B
YoY Change -15.07% -13.86% 0.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.268B $4.728B $3.897B
Total Long-Term Liabilities $25.76B $26.32B $30.55B
Total Liabilities $31.55B $34.55B $41.49B
YoY Change -21.65% -16.72% -1.2%
SHAREHOLDERS EQUITY
Retained Earnings -$2.725B -$3.239B -$4.614B
YoY Change -46.87% -29.8% 97.31%
Common Stock $10.47B $10.45B $10.36B
YoY Change 0.78% 0.9% 2.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.849B $5.327B $4.167B
YoY Change
Total Liabilities & Shareholders Equity $37.50B $39.97B $45.76B
YoY Change -13.86% -12.65% -5.56%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income $513.0M $1.300B -$1.219B
YoY Change -199.69% -206.64% -2457.83%
Depreciation, Depletion And Amortization $819.0M $698.0M $708.0M
YoY Change 15.84% -1.41% -2.53%
Cash From Operating Activities $578.0M $490.0M $569.0M
YoY Change 12.89% -13.88% -22.37%
INVESTING ACTIVITIES
Capital Expenditures -$72.00M -$48.00M -$91.00M
YoY Change 16.13% -47.25% -278.08%
Acquisitions
YoY Change
Other Investing Activities $162.0M $917.0M $22.00M
YoY Change 138.24% 4068.18% -120.95%
Cash From Investing Activities $90.00M $869.0M -$69.00M
YoY Change 1400.0% -1359.42% -55.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.842B -1.430B -697.0M
YoY Change 220.35% 105.16% 542.4%
NET CHANGE
Cash From Operating Activities $578.0M $490.0M $569.0M
Cash From Investing Activities 90.00M 869.0M -69.00M
Cash From Financing Activities -1.842B -1.430B -697.0M
Net Change In Cash $578.0M $490.0M $569.0M
YoY Change 12.89% -13.88% 21.5%
FREE CASH FLOW
Cash From Operating Activities $578.0M $490.0M $569.0M
Capital Expenditures -$72.00M -$48.00M -$91.00M
Free Cash Flow $650.0M $538.0M $660.0M
YoY Change 13.24% -18.48% -3.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000885590
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
324000000 USD
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
407000000 USD
CY2016Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
198000000 USD
CY2017Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
258000000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
dei Document Type
DocumentType
10-Q
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
348591928 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Valeant Pharmaceuticals International, Inc.
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
213000000 USD
CY2017Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
163000000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3227000000 USD
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3396000000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2108000000 USD
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1888000000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
351000000 USD
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
368000000 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
134000000 USD
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
70000000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
89000000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
100000000 USD
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3400000 shares
CY2016Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
148000000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
394000000 USD
CY2017Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
406000000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
629000000 USD
CY2016Q4 us-gaap Assets
Assets
43529000000 USD
CY2017Q3 us-gaap Assets
Assets
39974000000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
542000000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
964000000 USD
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
597000000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
5077000000 USD
CY2017Q3 us-gaap Assets Current
AssetsCurrent
5944000000 USD
CY2016Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
261000000 USD
CY2017Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
16000000 USD
CY2016Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-9000000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-18000000 USD
CY2017Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
238000000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
297000000 USD
CY2017Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
45000000 USD
CY2017Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
345000000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
659000000 USD
CY2016Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
659000000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
542000000 USD
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1969000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
62000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1427000000 USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
30000000 USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
0 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2017Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
347821606 shares
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
348582556 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
347821606 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
348582556 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
10038000000 USD
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
10086000000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1224000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1932000000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1379000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2118000000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-3000000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-3000000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1224000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1935000000 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1378000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2115000000 USD
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
649000000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1917000000 USD
CY2017Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
650000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
6137000000 USD
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30169000000 USD
CY2017Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
27426000000 USD
CY2017Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
6310000000 USD
CY2017Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
285000000 USD
CY2016Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0575
CY2017Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0609
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1869000000 USD
CY2016Q3 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
9000000 USD
us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
29000000 USD
CY2017Q3 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
9000000 USD
us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
32000000 USD
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
3342000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
7987000000 USD
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
2181000000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-18000000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
CY2016Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
146000000 USD
CY2017Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
166000000 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
5434000000 USD
CY2017Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2237000000 USD
CY2017Q3 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
925000000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1857000000 USD
CY2017Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2225000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2159000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2039000000 USD
CY2016Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
2132000000 USD
CY2017Q3 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
718000000 USD
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.47
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.40
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.47
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.69
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.38
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
6000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
39000000 USD
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
129000000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M10D
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
-297000000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
37000000 USD
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
892000000 USD
CY2017Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
390000000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9435000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11260000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
584000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1781000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1966000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2059000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2275000000 USD
CY2017Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-3000000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
26368000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
25359000000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16933000000 USD
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14099000000 USD
CY2016Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2000000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4000000 USD
CY2017Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
19000000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
87000000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
15000000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
83000000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
11000000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
695000000 USD
CY2016Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
9000000 USD
CY2017Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-25000000 USD
CY2016Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
32000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-112000000 USD
CY2017Q3 us-gaap Goodwill
Goodwill
15573000000 USD
CY2016 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1000000 USD
CY2016Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2017Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-65000000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
18553000000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
15794000000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
261000000 USD
CY2016Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2016Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1049000000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1049000000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
312000000 USD
CY2016 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
0 USD
CY2016 us-gaap Goodwill Transfers
GoodwillTransfers
-1378000000 USD
CY2016 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
5000000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1332000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2075000000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-400000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-937000000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-113000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-179000000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1700000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2829000000 USD
us-gaap Income Tax Reconciliation Disposition Of Business
IncomeTaxReconciliationDispositionOfBusiness
224000000 USD
CY2017Q3 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
-472000000 USD
us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-32000000 USD
CY2017Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-179000000 USD
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-334000000 USD
CY2017Q3 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
108000000 USD
CY2017Q3 us-gaap Income Tax Reconciliation Nondeductible Expense Restructuring Charges
IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
1397000000 USD
us-gaap Income Tax Reconciliation Nondeductible Expense Restructuring Charges
IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
2626000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
30000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
299000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-338000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
166000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-118000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-32000000 USD
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1900000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1300000 shares
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
28319000000 USD
CY2017Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
27283000000 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18884000000 USD
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16023000000 USD
CY2016Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
470000000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
1369000000 USD
CY2017Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
459000000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
1392000000 USD
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
337000000 USD
CY2017Q3 us-gaap Interest Payable Current
InterestPayableCurrent
385000000 USD
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
680000000 USD
CY2017Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
650000000 USD
CY2016Q4 us-gaap Inventory Gross
InventoryGross
1061000000 USD
CY2017Q3 us-gaap Inventory Gross
InventoryGross
1071000000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
1061000000 USD
CY2017Q3 us-gaap Inventory Net
InventoryNet
1071000000 USD
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
256000000 USD
CY2017Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
281000000 USD
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
125000000 USD
CY2017Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
140000000 USD
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
6000000 USD
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
9000000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
40271000000 USD
CY2017Q3 us-gaap Liabilities
Liabilities
34552000000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43529000000 USD
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39974000000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3609000000 USD
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4728000000 USD
CY2016Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
57000000 USD
CY2017Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0 USD
CY2016Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
57000000 USD
CY2017Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
461000000 USD
CY2016Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
184000000 USD
CY2017Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
265000000 USD
CY2017Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
133000000 USD
CY2017Q3 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
20000000 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
29846000000 USD
CY2017Q3 us-gaap Long Term Debt
LongTermDebt
27141000000 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1000000 USD
CY2017Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
925000000 USD
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3175000000 USD
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
5365000000 USD
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2000000 USD
CY2017Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
923000000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29845000000 USD
CY2017Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
26216000000 USD
CY2017Q2 us-gaap Loss Contingency Claims Settled Number
LossContingencyClaimsSettledNumber
2 claim
CY2016Q4 us-gaap Minority Interest
MinorityInterest
106000000 USD
CY2017Q3 us-gaap Minority Interest
MinorityInterest
95000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1388000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3121000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-131000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2797000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1575000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1712000000 USD
CY2016Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000000 USD
CY2017Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1218000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1894000000 USD
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1301000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1891000000 USD
CY2016 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
1 business
us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
0 business
CY2017Q3 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
100 country
CY2016Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-863000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-716000000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
38000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
424000000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
593000000 USD
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
684000000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
184000000 USD
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
152000000 USD
CY2016Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
1000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
2000000 USD
CY2017Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
3000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
4000000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-37000000 USD
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
81000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
227000000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
223000000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
107000000 USD
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
102000000 USD
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
78000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
12000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
24000000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
325000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
584000000 USD
CY2016Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
20000000 USD
CY2017Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
325000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
584000000 USD
CY2016Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
36000000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
103000000 USD
CY2017Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
33000000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
99000000 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
68000000 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
221000000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
96000000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
39000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
48000000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
146000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
4000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
181000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
118000000 USD
CY2016Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
195000000 USD
CY2017Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
198000000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
696000000 USD
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
736000000 USD
us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
0 USD
us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
60000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1220000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
6231000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-8000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-18000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
17000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
131000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3063000000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
3000000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
33000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2016Q3 us-gaap Profit Loss
ProfitLoss
-1219000000 USD
us-gaap Profit Loss
ProfitLoss
-1896000000 USD
CY2017Q3 us-gaap Profit Loss
ProfitLoss
1300000000 USD
us-gaap Profit Loss
ProfitLoss
1892000000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1312000000 USD
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1398000000 USD
CY2016Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
2517000000 USD
CY2017Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
2229000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1917000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
9249000000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
3000000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
8000000 USD
CY2016Q2 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.15
CY2016Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
101000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
328000000 USD
CY2017Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
81000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
271000000 USD
CY2016Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2016Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2017Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
928000000 USD
CY2016Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 USD
CY2017Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
77000000 USD
CY2016Q3 us-gaap Restructuring Charges
RestructuringCharges
20000000 USD
us-gaap Restructuring Charges
RestructuringCharges
78000000 USD
CY2017Q3 us-gaap Restructuring Charges
RestructuringCharges
6000000 USD
us-gaap Restructuring Charges
RestructuringCharges
42000000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5129000000 USD
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3239000000 USD
CY2016Q3 us-gaap Revenues
Revenues
2479000000 USD
us-gaap Revenues
Revenues
7271000000 USD
CY2017Q3 us-gaap Revenues
Revenues
2219000000 USD
us-gaap Revenues
Revenues
6561000000 USD
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2443000000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7168000000 USD
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2186000000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6462000000 USD
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
661000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2145000000 USD
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
623000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1943000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
134000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
70000000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
3152000000 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
5327000000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3258000000 USD
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5422000000 USD
CY2017Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
44000000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
346500000 shares
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
352300000 shares
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
39000000 USD
CY2017Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
257000000 USD
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
349500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
351400000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
349500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
346500000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
350400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
350100000 shares
CY2016Q4 vrx Accrued Product Rebate Current
AccruedProductRebateCurrent
897000000 USD
CY2017Q3 vrx Accrued Product Rebate Current
AccruedProductRebateCurrent
1039000000 USD
CY2016Q4 vrx Accrued Product Return Current
AccruedProductReturnCurrent
708000000 USD
CY2017Q3 vrx Accrued Product Return Current
AccruedProductReturnCurrent
815000000 USD
vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
38000000 USD
vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
0 USD
vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
96000000 USD
vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
71000000 USD
CY2016Q3 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
664000000 USD
vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
2015000000 USD
CY2017Q3 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
657000000 USD
vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
1915000000 USD
CY2016Q4 vrx Assumed Accrued Professional Feels Legal Liabilities
AssumedAccruedProfessionalFeelsLegalLiabilities
281000000 USD
CY2017Q3 vrx Assumed Accrued Professional Feels Legal Liabilities
AssumedAccruedProfessionalFeelsLegalLiabilities
52000000 USD
vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
18000000 USD
vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
-297000000 USD
CY2016Q4 vrx Business Combination Contingent Consideration Noncurrent Liability
BusinessCombinationContingentConsiderationNoncurrentLiability
840000000 USD
CY2017Q3 vrx Business Combination Contingent Consideration Noncurrent Liability
BusinessCombinationContingentConsiderationNoncurrentLiability
345000000 USD
vrx Debt Instrument Redemption Price Percentage Changein Control
DebtInstrumentRedemptionPricePercentageChangeinControl
1.01
CY2016Q3 vrx Deconsolidation Gain Loss Excluding Noncash Portion Amount
DeconsolidationGainLossExcludingNoncashPortionAmount
0 USD
vrx Deconsolidation Gain Loss Excluding Noncash Portion Amount
DeconsolidationGainLossExcludingNoncashPortionAmount
-19000000 USD
CY2017Q3 vrx Deconsolidation Gain Loss Excluding Noncash Portion Amount
DeconsolidationGainLossExcludingNoncashPortionAmount
0 USD
vrx Deconsolidation Gain Loss Excluding Noncash Portion Amount
DeconsolidationGainLossExcludingNoncashPortionAmount
0 USD
vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-310000000 USD
vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-2985000000 USD
vrx Effective Income Tax Rate Reconciliation Change In Deferred Tax Asset For Net Operating Loss
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetForNetOperatingLoss
679000000 USD
vrx Effective Income Tax Rate Reconciliation Changein Deferred Tax Liability Amount
EffectiveIncomeTaxRateReconciliationChangeinDeferredTaxLiabilityAmount
1947000000 USD
vrx Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reclassification To Held For Sale
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReclassificationToHeldForSale
168000000 USD
CY2017Q3 vrx Finite Lived Intangible Assets Amortization Expense Thereafter
FiniteLivedIntangibleAssetsAmortizationExpenseThereafter
3793000000 USD
CY2017Q3 vrx Finite Lived Intangible Assets Amortization Expense Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseYearSix
1641000000 USD
vrx Highly Liquid Investments Maturity Period
HighlyLiquidInvestmentsMaturityPeriod
P3M
CY2016Q4 vrx Intangible Assets Accumulated Amortizationand Impairment Losses
IntangibleAssetsAccumulatedAmortizationandImpairmentLosses
9435000000 USD
CY2017Q3 vrx Intangible Assets Accumulated Amortizationand Impairment Losses
IntangibleAssetsAccumulatedAmortizationandImpairmentLosses
11260000000 USD
CY2017Q3 vrx Long Term Debt Maturities Repayments Of Principal In Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix
6677000000 USD
CY2017Q3 vrx Long Term Debt Maturities Repayments Of Principal Thereafter
LongTermDebtMaturitiesRepaymentsOfPrincipalThereafter
11284000000 USD
CY2016Q3 vrx Other Income Expense Net
OtherIncomeExpenseNet
0 USD
vrx Other Income Expense Net
OtherIncomeExpenseNet
2000000 USD
CY2017Q3 vrx Other Income Expense Net
OtherIncomeExpenseNet
0 USD
vrx Other Income Expense Net
OtherIncomeExpenseNet
-1000000 USD
vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
27000000 USD
vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
3000000 USD
CY2016Q3 vrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
350300000 shares
vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
94000000 USD
vrx Paymentof Deferred Consideration
PaymentofDeferredConsideration
517000000 USD
vrx Paymentof Deferred Consideration
PaymentofDeferredConsideration
0 USD
vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
34000000 USD
vrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
349900000 shares
CY2016Q3 vrx Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
91000000 USD
vrx Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
301000000 USD
CY2017Q3 vrx Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
73000000 USD
vrx Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
245000000 USD
CY2016Q3 vrx Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
10000000 USD
vrx Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
27000000 USD
CY2017Q3 vrx Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
8000000 USD
vrx Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
26000000 USD
CY2016Q3 vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
31000000 USD
vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
34000000 USD
CY2017Q3 vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
0 USD
vrx Research And Development In Process And Other Charges
ResearchAndDevelopmentInProcessAndOtherCharges
5000000 USD
CY2016Q4 vrx Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
423000000 USD
CY2017Q3 vrx Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
500000000 USD
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform to the current year presentation.</font></div></div>
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valeant Pharmaceuticals International, Inc. (the &#8220;Company&#8221;) is a multinational, specialty pharmaceutical and medical device company, continued under the laws of the Province of British Columbia, that develops, manufactures, and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (&#8220;OTC&#8221;) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices) which are marketed directly or indirectly in over </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> countries.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing the unaudited consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company&#8217;s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company&#8217;s results of operations and financial position could be materially impacted.</font></div></div>

Files In Submission

Name View Source Status
0000885590-17-000070-index-headers.html Edgar Link pending
0000885590-17-000070-index.html Edgar Link pending
0000885590-17-000070.txt Edgar Link pending
0000885590-17-000070-xbrl.zip Edgar Link pending
exhibit311q32017.htm Edgar Link pending
exhibit312q32017.htm Edgar Link pending
exhibit321q32017.htm Edgar Link pending
exhibit322q32017.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
valeantq32017.htm Edgar Link pending
vrx-20170930.xml Edgar Link completed
vrx-20170930.xsd Edgar Link pending
vrx-20170930_cal.xml Edgar Link unprocessable
vrx-20170930_def.xml Edgar Link unprocessable
vrx-20170930_lab.xml Edgar Link unprocessable
vrx-20170930_pre.xml Edgar Link unprocessable